A Phase II, Randomized, Placebo-Controlled, Double Blind, Trial of Safety, Tolerability and Efficacy Study of Topical AKP-11 Administration to Participants with Arthritis.
A Phase I, Randomized, Placebo-Controlled, Double Blind, Trial of Safety, Tolerabilityand Efficacy Study of Topical AKP-11 Administration to Participants with Arthritis.
A Multicenter, Randomized, Double Blind, Placebo-controlled, Two-arm, Phase II Clinical study to evaluate Safety, Tolerability and Efficacy of Topical 1% AKP-11 in Atopic Dermatitis Participants.